Michael Salgaller | Supervisor, Invention Development And Marketing Unit
National Cancer Institute - NIH

WVIC/WAC Day 1 - Nov 29 @ 11:45

How can partnering with federal labs help your business?

Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute - NIH

×

Michael Salgaller / How can partnering with federal labs help your business?

Michael Salgaller, Supervisor, Invention Development And Marketing Unit,
National Cancer Institute - NIH

Experienced biopharma and life sciences senior manager with strong and successful background in technology development, entrepreneurship, business development, strategic planning, clinical and medical affairs, R&D, and capital formation.

Close

Michael Mowatt, Director, Technology Transfer And Intellectual Property Office, National Institute of Health - NIAID

×

Michael Mowatt / How can partnering with federal labs help your business?

Michael Mowatt, Director, Technology Transfer And Intellectual Property Office,
National Institute of Health - NIAID

Since 2001 Dr. Mowatt has directed the technology transfer program at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). His team of fifty talented professionals includes scientists, attorneys, and former business persons who facilitate...

CloseMore

WVIC/WAC Day 3 - Dec 1 @ 08:30

Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

• What are the advantages of partnering with big pharma, federal labs, accelerators, foundations and private investors?
• What are their programmatic interests of the players involved in getting technologies to market?
• What emerging technologies are those in charge of partnering and collaboration most excited about?
• How can you position yourself optimally to get your tech noticed?

Moderator: Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute - NIH

×

Michael Salgaller / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Michael Salgaller, Supervisor, Invention Development And Marketing Unit,
National Cancer Institute - NIH

Experienced biopharma and life sciences senior manager with strong and successful background in technology development, entrepreneurship, business development, strategic planning, clinical and medical affairs, R&D, and capital formation.

Close

Michael Mowatt, Director, Technology Transfer And Intellectual Property Office, National Institute of Health - NIAID

×

Michael Mowatt / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Michael Mowatt, Director, Technology Transfer And Intellectual Property Office,
National Institute of Health - NIAID

Since 2001 Dr. Mowatt has directed the technology transfer program at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). His team of fifty talented professionals includes scientists, attorneys, and former business persons who facilitate...

CloseMore

Alex Szidon, Chief Business Officer, Resilience

×

Alex Szidon / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Alex Szidon, Chief Business Officer,
Resilience

As Chief Business Officer, Alex Szidon is focused on strategic transactions that will help embed Resilience into the future of next-generation preventative, regenerative and curative therapies and vaccines. In this capacity, Alex and his team support and lead risk-sharing arrangements, equity...

CloseMore

Dr Michael Eichberg, Strategic Alliances Director, Merck

×

Dr Michael Eichberg / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Dr Michael Eichberg, Strategic Alliances Director,
Merck

Dr. Eichberg is Director of Strategic Alliances at Merck Research Laboratories, where he oversees collaborations in multiple therapeutic areas and with a variety of partners, including biopharmaceuticals, academic researchers, NGOs, and government agencies.  In this role, Dr. Eichberg is involved...

CloseMore

Lesley Stolz, Regional Vice President, Early Innovation Partnering, Johnson & Johnson Innovation

×

Lesley Stolz / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Lesley Stolz, Regional Vice President, Early Innovation Partnering,
Johnson & Johnson Innovation

Lesley is Regional Vice President, Early Innovation Partnering at Johnson & Johnson Innovation, California. In this role, she leads identification, incubation, due diligence, negotiation, execution and on-boarding for high-impact partnerships and collaborations in external innovation. Lesley...

CloseMore

Jaione Maiz, Principal, Anzu Partners

×

Jaione Maiz / Accelerating innovation –leveraging partnerships and collaborations to advance solutions to ID & Cancer

Jaione Maiz, Principal,
Anzu Partners

Dr. Jaione Maiz is a Principal at Anzu Partners with a focus on investing at the intersections of life science and innovative technology. She also supports portfolio companies in business development, strategy, and product development. Prior to Anzu, Jaione was a Director of Business Development at ...

CloseMore